Amalgamated Bank Has $2.89 Million Holdings in The Clorox Company $CLX

by · The Cerbat Gem

Amalgamated Bank lowered its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,088 shares of the company’s stock after selling 2,300 shares during the period. Amalgamated Bank’s holdings in Clorox were worth $2,892,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in CLX. American National Bank & Trust lifted its holdings in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in Clorox during the 2nd quarter worth approximately $31,000. Ransom Advisory Ltd acquired a new stake in Clorox during the 1st quarter worth approximately $35,000. GW&K Investment Management LLC lifted its holdings in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after purchasing an additional 208 shares during the last quarter. Finally, Bogart Wealth LLC lifted its holdings in Clorox by 289.5% during the 2nd quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock worth $44,000 after purchasing an additional 275 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CLX shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. Barclays dropped their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research report on Tuesday, September 30th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Clorox from $135.00 to $128.00 and set a “hold” rating for the company in a research report on Monday, October 13th. UBS Group dropped their price target on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Finally, Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 28th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $130.20.

Get Our Latest Stock Report on Clorox

Insider Buying and Selling at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Stock Down 2.9%

Shares of CLX opened at $109.16 on Tuesday. The firm has a 50 day simple moving average of $120.28 and a two-hundred day simple moving average of $125.61. The company has a market cap of $13.29 billion, a P/E ratio of 16.74, a P/E/G ratio of 0.92 and a beta of 0.52. The Clorox Company has a one year low of $108.93 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company’s revenue was down 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s payout ratio is presently 76.07%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).